NewGenIvf Group (NIVF) Competitors $1.23 -0.80 (-39.41%) Closing price 10/17/2025 04:00 PM EasternExtended Trading$1.18 -0.05 (-4.39%) As of 10/17/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NIVF vs. BRTX, BGLC, ACON, KDLY, DHAC, VSEE, BACK, OTRK, BTTX, and UPHLShould you be buying NewGenIvf Group stock or one of its competitors? The main competitors of NewGenIvf Group include Biorestorative Therapies (BRTX), BioNexus Gene Lab (BGLC), Aclarion (ACON), Kindly MD (KDLY), Digital Health Acquisition (DHAC), VSee Health (VSEE), IMAC (BACK), Ontrak (OTRK), Better Therapeutics (BTTX), and UpHealth (UPHL). These companies are all part of the "healthcare" industry. NewGenIvf Group vs. Its Competitors Biorestorative Therapies BioNexus Gene Lab Aclarion Kindly MD Digital Health Acquisition VSee Health IMAC Ontrak Better Therapeutics UpHealth NewGenIvf Group (NASDAQ:NIVF) and Biorestorative Therapies (NASDAQ:BRTX) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, earnings, dividends, institutional ownership, media sentiment, valuation, profitability and analyst recommendations. Does the media favor NIVF or BRTX? In the previous week, Biorestorative Therapies had 1 more articles in the media than NewGenIvf Group. MarketBeat recorded 2 mentions for Biorestorative Therapies and 1 mentions for NewGenIvf Group. Biorestorative Therapies' average media sentiment score of 0.38 beat NewGenIvf Group's score of 0.28 indicating that Biorestorative Therapies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NewGenIvf Group 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Biorestorative Therapies 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has preferable valuation and earnings, NIVF or BRTX? NewGenIvf Group has higher revenue and earnings than Biorestorative Therapies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNewGenIvf Group$5.43M0.49-$520KN/AN/ABiorestorative Therapies$400K31.62-$8.98M-$1.27-1.25 Do insiders and institutionals hold more shares of NIVF or BRTX? 66.2% of NewGenIvf Group shares are held by institutional investors. Comparatively, 69.4% of Biorestorative Therapies shares are held by institutional investors. 31.8% of NewGenIvf Group shares are held by insiders. Comparatively, 30.8% of Biorestorative Therapies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Is NIVF or BRTX more profitable? NewGenIvf Group has a net margin of 0.00% compared to Biorestorative Therapies' net margin of -1,772.40%. NewGenIvf Group's return on equity of 0.00% beat Biorestorative Therapies' return on equity.Company Net Margins Return on Equity Return on Assets NewGenIvf GroupN/A N/A N/A Biorestorative Therapies -1,772.40%-137.00%-88.31% Which has more volatility & risk, NIVF or BRTX? NewGenIvf Group has a beta of -0.06, indicating that its share price is 106% less volatile than the S&P 500. Comparatively, Biorestorative Therapies has a beta of -0.69, indicating that its share price is 169% less volatile than the S&P 500. Do analysts rate NIVF or BRTX? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NewGenIvf Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00Biorestorative Therapies 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 SummaryNewGenIvf Group beats Biorestorative Therapies on 7 of the 11 factors compared between the two stocks. Get NewGenIvf Group News Delivered to You Automatically Sign up to receive the latest news and ratings for NIVF and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NIVF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NIVF vs. The Competition Export to ExcelMetricNewGenIvf GroupMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.36M$8.29B$6.10B$10.50BDividend YieldN/A2.14%5.73%4.81%P/E RatioN/A73.2484.5227.09Price / Sales0.4933.15585.94210.58Price / CashN/A21.6337.1661.22Price / Book-0.016.8312.246.52Net Income-$520K$247.60M$3.32B$276.75M7 Day Performance-32.04%-0.33%1.25%2.00%1 Month Performance-34.22%-4.55%6.28%2.26%1 Year Performance-99.90%4.69%59.92%35.58% NewGenIvf Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NIVFNewGenIvf GroupN/A$1.23-39.4%N/A-99.9%$4.36M$5.43M0.00N/AGap DownHigh Trading VolumeBRTXBiorestorative Therapies1.3463 of 5 stars$1.61+0.3%N/A-5.7%$12.81M$400K-1.267BGLCBioNexus Gene Lab0.7719 of 5 stars$5.12-4.2%N/A+36.3%$9.18M$9.51M0.0030Positive NewsShort Interest ↓ACONAclarion2.2671 of 5 stars$9.43-2.6%$11,758.50+124,539.6%-99.5%$5.47M$50K0.007Gap DownKDLYKindly MDN/A$0.86-1.6%N/A-38.0%$5.16M$2.47M-1.11N/AHigh Trading VolumeDHACDigital Health AcquisitionN/A$0.69-2.1%N/A-55.5%$2.47MN/A0.002,021High Trading VolumeVSEEVSee Health2.5414 of 5 stars$0.63-1.9%$5.00+700.0%-65.4%$2.25M$10.42M0.00N/ANews CoverageEarnings ReportShort Interest ↑BACKIMACN/A$0.08-3.7%N/A-94.5%$164K$72.05K0.00180Gap DownOTRKOntrak1.4939 of 5 stars$0.02-24.9%$3.00+13,536.4%-99.0%$93K$10.18M0.00250Gap DownBTTXBetter TherapeuticsN/A$0.00flatN/A+0.0%$5KN/A0.0040UPHLUpHealthN/A$0.00flatN/A-98.2%$4K$130M0.001,750 Related Companies and Tools Related Companies Biorestorative Therapies Alternatives BioNexus Gene Lab Alternatives Aclarion Alternatives Kindly MD Alternatives Digital Health Acquisition Alternatives VSee Health Alternatives IMAC Alternatives Ontrak Alternatives Better Therapeutics Alternatives UpHealth Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NIVF) was last updated on 10/18/2025 by MarketBeat.com Staff From Our PartnersBuy alert: Move $1,000 before Tesla’s Optimus launchElon's $1,000,000,000,000 payday Elon Musk just made his biggest insider purchase of Tesla stock ever. He's...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredNvidia’s slow death marchEric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredThe Truth about AI Stocks’ Money MachineBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredNext opportunity for crypto millionsThe floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NewGenIvf Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share NewGenIvf Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
